Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis
article
OA: closed
CC0
⤵ 110 in-corpus citations
AI-generated summary
This study investigated how oral contraceptive use and reproductive history affect the risk of epithelial ovarian cancer in women, both with and without a history of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveWomen with endometriosis may be at an increased risk of ovarian cancer. It is not known whether reproductive factors that reduce the risk of ovarian cancer in general also reduce risk in women with endometriosis. We investigated whether the odds ratios for ovarian cancer that were associated with oral contraceptive use, childbearing, hysterectomy, and tubal ligation differ among women with and without endometriosis.Study designWe pooled information on the self-reported history of endometriosis from 4 population-based case-controlled studies of incident epithelial ovarian cancer, comprising 2098 cases and 2953 control subjects. We obtained data on oral contraceptive use, childbearing, breastfeeding, gynecologic surgical procedures, and other reproductive factors on each woman. Multivariable unconditional logistic regression was used to calculate odds ratios and 95% CI for ovarian cancer among women with endometriosis compared with women without endometriosis. Similar methods were used to assess the frequencies of risk factors among women with and without endometriosis. Adjustments were made for age, parity, oral contraceptive use, tubal ligation, family history of ovarian cancer, and study site.ResultsWomen with endometriosis were at an increased risk of ovarian cancer (odds ratio, 1.32; 95% CI, 1.06-1.65). Using oral contraceptives, bearing children, and having a tubal ligation or hysterectomy were associated with a similar reduction in the odds ratios for ovarian cancer among women with and without endometriosis. In particular, the use of oral contraceptives for >10 years was associated with a substantial reduction in risk among women with endometriosis (odds ratio, 0.21; 95% CI, 0.08-0.58).ConclusionWomen with endometriosis are at an increased risk of epithelial ovarian cancer. Long-term oral contraceptive use may provide substantial protection against the disease in this high-risk population.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- <b>Ovarian atypical endometriosis: its close association with malignant epithelial tumours</b> via openalex
- Cancer risk after a hospital discharge diagnosis of endometriosis via openalex
- Endometrioid Adenocarcinoma of the Ovary and Its Relationship to Endometriosis via openalex
- Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. via openalex
- Endometriosis and ovarian cancer via openalex
- Endometriosis and ovarian cancer: Thoughts on shared pathophysiology via openalex
- Endometriosis: novel etiopathogenetic concepts and clinical perspectives via openalex
- Epidemiologic determinants of endometriosis: A hospital-based case-control study via openalex
- Epidemiology of endometriosis in women attending family planning clinics. via openalex
- High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis via openalex
- Histologic Transformation of Benign Endometriosis to Early Epithelial Ovarian Cancer via openalex
- Pelvic endometriosis: reproductive and menstrual risk factors at different stages in Lombardy, northern Italy. via openalex
- The Epidemiology of Endometriosis via openalex
- W2137849078 via openalex
- W2146239695 via openalex
- W2154804898 via openalex
- W2162556755 via openalex
- W2165380658 via openalex
- W2166310305 via openalex
- W2735861455 via openalex
- W3085323863 via openalex
- W4237784496 via openalex
- W6632590420 via openalex
- W6641505065 via openalex
- W6668422253 via openalex
- W6683758114 via openalex
- W949594811 via openalex
- W6683952698 via openalex
- W1544533071 via openalex
- W1592007606 via openalex
- W1983679820 via openalex
- W1989571956 via openalex
- W1994424229 via openalex
- W2033352851 via openalex
- W2047974520 via openalex
- W2061398936 via openalex
- W2072270562 via openalex
- W2124132382 via openalex
- W2126560499 via openalex
- W2134825071 via openalex
Cited by (50)
- Guideline No. 468: Clinical Management of Endometriosis 2026
- Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making 2026
- Endometriosis and ovarian cancer risk 2026
- Risk, Prevalence and Survival Outcomes of Ovarian Cancer in Women with Endometriosis: The ENDOCANCER Systematic Review and Meta-Analysis 2026
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- Untreated ovarian endometrioma: not just a matter of dimensional change over time 2025
- Reply 2025
- The long road of drug development for endometriosis - Pains, gains, and hopes 2024
- Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions 2023
- Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer 2023
- Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy 2023
- In the thicket of fears, doubts, and murky facts: some reflections on treatment modalities for endometriosis-associated pain 2023
- Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy 2022
- Endometriosis: not just a benign disease 2022
- Malignancy Risks Associated with Endometriosis: Clinical Aspects 2022
- A case of an endometriosis associated ovarian carcinoma that could not be diagnosed by preoperative MRI 2022
- Effects of risk factors for ovarian cancer in women with and without endometriosis 2022
- Endometriosis and endometriosis associated ovarian cancer 2021
- Endometriosis and risk of ovarian cancer 2021
- Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma 2021
- The relation between endometrioma and ovarian cancer 2021
- Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association 2021
- Progestogens and Endometriosis 2021
- Long-Term Health Consequences of Endometriosis—Pathways and Mediation by Treatment 2020
- Should All Endometriotic Cysts Be Removed? 2020
- Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy 2020
- Endometriosis and Cancer: Prevention and Diagnosis 2020
- Malignant extra‐ovarian endometriosis: A case series of ten patients and review of the literature 2020
- The association between parity and the risk of endometriosis: a meta-analysis 2020
- Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study 2020
- Endometriosis and Endometriosis-Associated Ovarian Cancer (EAOC) 2020
- Endometriosis and cancer: a systematic review and meta-analysis 2020
- Endometriosis in Adolescent Girls 2020
- The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study 2019
- Endometriosis: seeking optimal management in women approaching menopause 2019
- Epithelial Mutations in Endometriosis: Link to Ovarian Cancer 2019
- A Systematic Review and Bioinformatics Study on Genes and micro-RNAs Involving the Transformation of Endometriosis into Ovarian Cancer 2019
- The Endometriotic Tumor Microenvironment in Ovarian Cancer 2018
- Définition, description, formes anatomo-cliniques, pathogenèse et histoire naturelle de l’endométriose, RPC Endométriose CNGOF-HAS 2018
- Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis 2018
- Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? 2018
- Epidemiological and Clinical Risk Factors for Endometriosis 2017
- Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care 2017
- Endometriosis 2016
- Endometriosis-associated Malignancy 2016
- Creativity and individuality in matters of hormonal contraception 2016
- Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review 2016
- Malignome auf dem Boden einer Endometriose 2016
- The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses 2016
- Estrogen-progestins and progestins for the management of endometriosis 2016
Source provenance
- europepmc
- last seen: 2026-07-25T06:15:30.875455+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:26.305326+00:00
License: CC0
· commercial use OK